{"id":101,"date":"2024-01-30T11:07:06","date_gmt":"2024-01-30T15:07:06","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/?p=101"},"modified":"2024-02-22T11:38:12","modified_gmt":"2024-02-22T15:38:12","slug":"senator-calls-on-inhaler-companies-to-stop-unfair-practices","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2024\/01\/30\/senator-calls-on-inhaler-companies-to-stop-unfair-practices\/","title":{"rendered":"Senator Calls on Inhaler Companies to Stop Unfair Practices"},"content":{"rendered":"<p>Senator Tammy Baldwin (D-WI)\u00a0<a href=\"https:\/\/www.baldwin.senate.gov\/news\/press-releases\/senator-baldwin-demands-big-pharma-stop-unfair-practices-that-reduce-competition-raise-prices-for-inhalers\">sent letters<\/a> on January 29 to companies warning of improper Orange Book listings of patents for inhalers, following up on the <a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2023\/11\/08\/ftc-issues-notice-letters-regarding-orange-book-listings\/\">FTC\u2019s focus<\/a>\u00a0on potential anticompetitive harm of improper listings.<\/p>\n<p><strong><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2024\/01\/30\/senator-reiterates-ftc-warnings-regarding-inhaler-patents-in-orange-book\/\" target=\"_blank\" rel=\"noopener\">Read more on the Duane Morris Life Sciences Law Blog.\u00a0<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Senator Tammy Baldwin (D-WI)\u00a0sent letters on January 29 to companies warning of improper Orange Book listings of patents for inhalers, following up on the FTC\u2019s focus\u00a0on potential anticompetitive harm of improper listings. Read more on the Duane Morris Life Sciences Law Blog.\u00a0<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[11,16,34,35,13],"ppma_author":[5],"class_list":["post-101","post","type-post","status-publish","format-standard","hentry","category-general","tag-antitrust","tag-ftc","tag-orange-book","tag-patents","tag-sarah-olaughlin-kulik"],"authors":[{"term_id":5,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/7e1f720079bb9c5f7f3d02f11a102b31d50b9071b40283de6cf5ac7a5e6f35b7?s=96&d=blank&r=g","author_category":"1","last_name":"Davies","first_name":"Thomas","job_title":"","user_url":"https:\/\/www.duanemorris.com","description":"<a href=\"http:\/\/www.duanemorris.com\">Visit the Duane Morris website.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/comments?post=101"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/101\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/media?parent=101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/categories?post=101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/tags?post=101"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/ppma_author?post=101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}